Oppenheimer & Co’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Oppenheimer & Co’s Portfolio IBDR Stock Details IBDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Sell	10,516 -5,171	-33%	-$125K	﹤0.01%	1459
2025 Q4	$380K	Buy	15,687 +1,161	+8%	+$28.1K	0.01%	1180
2025 Q3	$353K	Buy	14,526 +1,193	+9%	+$28.9K	﹤0.01%	1318
2025 Q2	$323K	Buy	13,333 +159	+1%	+$3.84K	﹤0.01%	1319
2025 Q1	$319K	Buy	13,174 +579	+5%	+$14K	﹤0.01%	1244
2024 Q4	$303K	Sell	12,595 -2	-0%	-$48	﹤0.01%	1261
2024 Q3	$306K	Buy	+12,597	New	+$303K	﹤0.01%	1219

Other funds holding IBDR

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.47B AUM 18.47% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Oppenheimer & Co's IBDR Position: Q1 2026 in Review

Oppenheimer & Co reduced its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) stake by 33% in Q1 2026, selling an estimated $125K and leaving 10,516 shares worth $255K. The position accounts for ﹤0.01% of the portfolio, ranked #1459.

Oppenheimer & Co first reported a position in IBDR in Q3 2024 and has held it in 7 quarters since. The position peaked at $380K in Q4 2025. 439 funds tracked by Wall St. Rank hold IBDR as of Q1 2026.

Oppenheimer & Co held 10,516 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $255K as of Q1 2026.
Oppenheimer & Co sold 5,171 iShares iBonds Dec 2026 Term Corporate ETF shares in Q1 2026, an estimated $125K.
iShares iBonds Dec 2026 Term Corporate ETF made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1459 holding.
Oppenheimer & Co first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q3 2024 and has held it in 7 quarters since.
Oppenheimer & Co's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $380K in Q4 2025.
439 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.